QUEEN MARY UNIVERSITY OF LONDON

🇬🇧United Kingdom

Country: 🇬🇧United Kingdom

Ownership: Private

Established: 1882-01-08

Employees: 1K

Market Cap: -

Website: http://www.qmul.ac.uk

Clinical Trials

Enhancing Diagnosis and Prevention of Cardiovascular Disease in Newham by Integrated Use of Electronic Health Records

Not Applicable

Completed

Conditions: Cardiovascular Disease

Interventions: Other: Enhanced Health Check

First Posted Date: 2015-07-01

Last Posted Date: 2018-03-06

Lead Sponsor: Queen Mary University of London

Target Recruit Count: 190

Registration Number: NCT02486913

Locations: 🇬🇧
Bart's Heart Centre, London, United Kingdom

Study of Gemcitabine/Carboplatin First-line Chemotherapy +/- Apatorsen in Advanced Squamous Cell Lung Cancers

Phase 2

Conditions: Squamous Cell Lung Cancer

Interventions: Drug: Apatorsen (OGX-427)
Drug: Gemcitabine
Drug: Carboplatin

First Posted Date: 2015-04-22

Last Posted Date: 2017-08-22

Lead Sponsor: Queen Mary University of London

Target Recruit Count: 140

Registration Number: NCT02423590

Locations: 🇬🇧
Medway NHS Foundation Trust, Gillingham, Kent, United Kingdom
🇬🇧
Barts Health NHS Trust, London, United Kingdom
🇬🇧
University Hospitals Bristol NHS Foundation Trust, Bristol, United Kingdom

and more 17 locations

PAKT: AZD5363 in Combination With Paclitaxel in Triple-Negative Advanced or Metastatic Breast Cancer

Phase 2

Active, not recruiting

Conditions: Metastatic Breast Cancer

Interventions: Drug: Paclitaxel
Drug: AZD5363
Drug: Placebo

First Posted Date: 2015-04-22

Last Posted Date: 2024-06-20

Lead Sponsor: Queen Mary University of London

Target Recruit Count: 140

Registration Number: NCT02423603

Locations: 🇭🇺
University of Pécs - Clinical Center Institute of Oncotherapy, Pécs, Hungary
🇷🇴
Center of Oncology Euroclinic, Iași, Romania
🇫🇷
ICO René Gauducheau, Nantes, France

and more 43 locations

UK Trial of Percutaneous Tibial Nerve Stimulation in Patients With Faecal Incontinence

Phase 3

Completed

Conditions: Bowel Incontinence
Faecal Incontinence

Interventions: Device: Percutaneous Tibial Nerve Stimulation

First Posted Date: 2015-01-28

Last Posted Date: 2015-01-28

Lead Sponsor: Queen Mary University of London

Target Recruit Count: 227

Registration Number: NCT02349334

ESTEEM - Effect of Simple, Targeted Diet in Pregnant Women With Metabolic Risk Factors on Pregnancy Outcomes

Not Applicable

Completed

Conditions: Obesity
Pre-eclampsia
Small for Gestational Age
Stillbirth
Gestational Diabetes
Raised Lipids
High Blood Pressure
Insulin Resistance

Interventions: Other: Non-randomised cohort
Behavioral: Targeted ESTEEM diet

First Posted Date: 2014-08-18

Last Posted Date: 2017-11-17

Lead Sponsor: Queen Mary University of London

Target Recruit Count: 3442

Registration Number: NCT02218931

Locations: 🇬🇧
Barts Health NHS Trust, London, United Kingdom

A Randomized Study of AZD2014 in Combination With Fulvestrant in Metastatic or Advanced Breast Cancer

Phase 2

Completed

Conditions: Estrogen Receptor Positive Breast Cancer

Interventions: Drug: Everolimus
Drug: AZD2014
Drug: Fulvestrant

First Posted Date: 2014-08-15

Last Posted Date: 2024-12-02

Lead Sponsor: Queen Mary University of London

Target Recruit Count: 333

Registration Number: NCT02216786

Locations: 🇬🇪
Tbilisi Cancer Center, Tbilisi, Georgia
🇵🇹
Ipo Porto, Porto, Portugal
🇭🇺
Bacs-Kiskun County Hospital, Kalocsa, Hungary

and more 76 locations

Study to Measure the Effect of Part Time Versus Full Time Orthodontic Appliance Wear

Not Applicable

Conditions: Class II Division 1 Malocclusion

Interventions: Device: Modified Clark Twin Block

First Posted Date: 2014-07-15

Last Posted Date: 2017-01-04

Lead Sponsor: Queen Mary University of London

Target Recruit Count: 62

Registration Number: NCT02190630

Locations: 🇬🇧
Dental Insitiute Royal London Hospital, London, United Kingdom

Anterior Resection Syndrome Following Sphincter-preserving Surgery

Completed

Conditions: Rectal Cancer

First Posted Date: 2014-07-15

Last Posted Date: 2016-04-05

Lead Sponsor: Queen Mary University of London

Target Recruit Count: 1197

Registration Number: NCT02190656

Locations: 🇬🇧
Queen Mary University of London, London, United Kingdom

Characterising Metastatic Penile Cancer Using Molecular Imaging - Hybrid MRI-PET [MRI-PET]

Completed

Conditions: Squamous Cell Carcinoma of the Penis

Interventions: Procedure: MRI-PET

First Posted Date: 2014-04-04

Last Posted Date: 2024-07-08

Lead Sponsor: Queen Mary University of London

Target Recruit Count: 107

Registration Number: NCT02104063

Locations: 🇬🇧
University College London Hospitals, London, United Kingdom

Protective Role of Oxcarbazepine in Multiple Sclerosis

Phase 2

Completed

Conditions: Multiple Sclerosis

Interventions: Drug: Placebo
Drug: Oxcarbazepine

First Posted Date: 2014-04-04

Last Posted Date: 2018-04-18

Lead Sponsor: Queen Mary University of London

Target Recruit Count: 30

Registration Number: NCT02104661

Locations: 🇬🇧
Barts Health NHS Trust, London, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy